Objective:
To discuss the evolution of extractables testing in pharmaceutical companies through advancements in mass spectrometry technology.
Approach:
- Expert Insight: Kate Comstock shares her extensive experience in extractables testing and the technological advancements in mass spectrometry.
Key Findings:
- The discipline of extractables testing has evolved significantly due to technological advancements.
- Orbitrap based mass spectrometry represents a key development in the field.
Interpretation:
Conclusion:
The evolution of extractables testing is closely tied to advancements in mass spectrometry technology.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.